EVP Research · REGENERON PHARMACEUTICALS, INC. · Common Stock
Side
A
Value
—
Shares
3,715
Price
—
Executed
Dec 5, 2025
Disclosed
Dec 9, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 5 executedDec 9, 2025 disclosed
REGN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 7.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Murphy Andrew J filed this Form 4 reporting a grant or award of REGN on Dec 5, 2025. It became public on Dec 9, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP Research
Murphy Andrew Jcik:0001796226
Issuer
REGENERON PHARMACEUTICALS, INC.cik:0000872589
Revision history · 0
No field has changed since this record was first ingested.
